Benefits of sphingosine-1-phosphate receptor modulators in relapsing MS estimated with a treatment sequence model https://www.medrxiv.org/content/10.1101/2022.12.23.22283885
QOTO: Question Others to Teach Ourselves An inclusive, Academic Freedom, instance All cultures welcome. Hate speech and harassment strictly forbidden.